Insider Transactions in Q3 2020 at Eli Lilly & CO (LLY)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$1,963
$151.18 P/Share
|
|
Sep 08
2020
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
SELL
Open market or private sale
|
Direct |
5,000
-17.49%
|
$755,000
$151.01 P/Share
|
|
Sep 01
2020
|
Michael B Mason EVP & Pres., Lilly Diabetes |
SELL
Payment of exercise price or tax liability
|
Direct |
2,735
-12.85%
|
$404,780
$148.39 P/Share
|
|
Sep 01
2020
|
Michael B Mason EVP & Pres., Lilly Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct |
6,244
+22.69%
|
-
|
|
Aug 17
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$1,963
$151.53 P/Share
|
|
Aug 17
2020
|
Stephen F Fry SVP, HR & Diversity |
SELL
Open market or private sale
|
Direct |
7,204
-6.71%
|
$1,080,600
$150.64 P/Share
|
|
Jul 20
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.02%
|
$2,004
$167.04 P/Share
|
|
Jul 09
2020
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct |
11,000
-37.1%
|
$1,870,000
$170.0 P/Share
|
|
Jul 09
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
12,961
-0.01%
|
$2,203,370
$170.0 P/Share
|
|
Jul 07
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.09%
|
$35,070,000
$167.49 P/Share
|
|
Jul 06
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.06%
|
$34,235,000
$167.41 P/Share
|
|
Jul 05
2020
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,114
-20.54%
|
$181,582
$163.87 P/Share
|
|
Jul 05
2020
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,468
+31.27%
|
-
|